Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Københavns Universitets forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Profiler
Publikation
Forskningsenheder
Presse/medier
Aktiviteter
Priser
???studenttheses???
Forskningsdatasæt
Søg efter ekspertise, navn eller tilknytning
Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited
Jan Hansen,
Birgitte Brock
, Hans Erik Bøtker,
Albert Gjedde
, Jørgen Rungby, Michael Gejl
9
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Medicine and Dentistry
Glucagon Like Peptide 1
100%
Glucose Metabolism
100%
Dipeptidyl Peptidase-4 Inhibitor
42%
Cardiovascular Effect
28%
Incretin
28%
Glucagon Like Peptide 1 Receptor
14%
Maturity Onset Diabetes of the Young
14%
Heart Left Ventricle Ejection Fraction
14%
Cardiovascular Disease
14%
Dipeptidyl Peptidase IV
14%
Energy Transfer
14%
Endothelial Function
14%
Cardiovascular System
14%
Gastrointestinal Hormone
14%
Atherosclerosis
14%
Ischemia
14%
Glucose Uptake
14%
Blood Glucose
14%
Cardiovascular Risk
14%
Heart Muscle Perfusion
14%
Blood Pressure
14%
Body Weight
14%
Keyphrases
Glucagon-like
100%
Dipeptidyl peptidase-4 (DPP-4)
50%
Cardiovascular Effects
37%
Glucagon-like peptide-1 Receptor (GLP-1R)
12%
Myocardial Perfusion
12%
Myocardial Glucose Uptake
12%
Atherosclerosis Development
12%
Endothelial Function
12%
Limited Information
12%
Myocardial Metabolism
12%
Cardiac Safety
12%
Beneficial Effects
12%
Blood Pressure
12%
Decreased Risk
12%
Real Patients
12%
A1 Receptor
12%
Protective Effect
12%
Type 2 Diabetes Prevention
12%
Cardiovascular Risk Profile
12%
Development Functions
12%
Ischemia
12%
Cardiovascular Disease
12%
Insulinotropic Effects
12%
Rapid Degradation
12%
Left Ventricular Ejection Fraction
12%
Gut Hormones
12%
Blood Glucose
12%
Dogma
12%
Incretin Effect
12%
Incretin
12%
Pharmacology, Toxicology and Pharmaceutical Science
Glucagon-Like Peptide-1
100%
Dipeptidyl Peptidase IV Inhibitor
42%
Incretin
28%
Atherosclerosis
14%
Ischemia
14%
Cardiovascular Risk
14%
Cardiovascular Disease
14%
Glucagon-Like Peptide 1 Receptor
14%
Non Insulin Dependent Diabetes Mellitus
14%
Gastrointestinal Hormone
14%
Dipeptidyl Peptidase IV
14%